BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

VIRTUS PHARMACEUTICALS — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

VIRTUS PHARMACEUTICALS

via RED+BLUE STRATEGIES

4th Quarter (Oct 1 - Dec 31) · 2016Posted Jan 4, 2017Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: VIRTUS PHARMACEUTICALS
Description: Generic Pharmaceutical Company
Location: Florida · United States of America

Registrant

Firm: RED+BLUE STRATEGIES
Description: Health Care Consulting
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to the treatment of certain generic medications
Lobbyistsms MELANIE JAN NATHANSON · ms MEGAN HAUCK MARSHALL
TargetedSENATE · Food & Drug Administration (FDA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.